J&J in Takeover Talks with Synthes

April 18, 2011
Deal could be valued at $20 billion

Swiss medical technology group Synthes said on March 18 that it is in takeover talks with healthcare giant Johnson & Johnson.

"In response to market speculation, Synthes Inc confirms that it is engaged in discussions with Johnson & Johnson about a potential business combination transaction," the medical equipment maker said.

It added it could not give further details or any assurances about potential transactions.

The Wall Street Journal reported on March 15 that the US group is in talks to buy Synthes in a deal that could be valued at around $20 billion.

Such a transaction could boost Johnson & Johnson's medical equipment business, which made up 40% of its 2010 revenues.

Shares in Synthes soared following the confirmation, trading up 6.71% at 148 francs, bucking the trend of the overall Swiss Market Index which was down 1.26%.

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!